ALGN - Align Technology, Inc.
NASDAQ
->
Healthcare
->
Medical Devices
Tempe,
United States
Type: Equity
ALGN price evolution
ALGN
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $761.43 | $865.8 | $937.44 | |
| Short term investments | $20.68 | $33.1 | $35.3 | |
| Net receivables | $1010.6 | $1020.13 | $950.74 | $903.42 |
| Inventory | $254.12 | $259.49 | $280.08 | $296.9 |
| Total current assets | $2597.39 | $2412.37 | $2479.31 | $2446.62 |
| Long term investments | $3.62 | $8.02 | ||
| Property, plant & equipment | $1411.51 | $1400 | $1400.7 | $1408.86 |
| Goodwill & intangible assets | $570.2 | $579.66 | $501.65 | |
| Total noncurrent assets | $3745.95 | $3676.44 | $3637.26 | |
| Total investments | $20.68 | $36.72 | $43.33 | |
| Total assets | $6365.97 | $6158.32 | $6155.75 | $6083.88 |
| Current liabilities | ||||
| Accounts payable | $109.03 | $105.79 | $117.24 | $113.13 |
| Deferred revenue | $1378.87 | $1409.2 | $1427.71 | |
| Short long term debt | ||||
| Total current liabilities | $2063.61 | $2040.12 | $2023.04 | $2066.61 |
| Long term debt | $98.3 | $95.09 | $96.97 | |
| Total noncurrent liabilities | $360.3 | $372.85 | $386.78 | |
| Total debt | $98.3 | $95.09 | $96.97 | |
| Total liabilities | $2421.62 | $2400.42 | $2395.89 | $2453.39 |
| Shareholders' equity | ||||
| Retained earnings | $2572.53 | $2456.56 | $2502.68 | $2447.17 |
| Other shareholder equity | $3944.35 | $3757.91 | $18.44 | $3630.49 |
| Total shareholder equity | $3757.91 | $3759.86 | $3630.49 | |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $937.44 | $942.05 | $1099.37 | $960.84 |
| Short term investments | $35.3 | $57.53 | $71.97 | |
| Net receivables | $903.42 | $859.68 | $897.2 | $657.7 |
| Inventory | $296.9 | $338.75 | $230.23 | $139.24 |
| Total current assets | $2446.62 | $2424.39 | $2494.07 | $1849.54 |
| Long term investments | $8.02 | $41.98 | $125.32 | |
| Property, plant & equipment | $1408.86 | $1350.73 | $1203.18 | $817.27 |
| Goodwill & intangible assets | $501.65 | $503.27 | $528.26 | $574.89 |
| Total noncurrent assets | $3637.26 | $3523.56 | $3448.03 | $2980.14 |
| Total investments | $43.33 | $99.51 | $197.29 | |
| Total assets | $6083.88 | $5947.95 | $5942.11 | $4829.68 |
| Current liabilities | ||||
| Accounts payable | $113.13 | $127.87 | $163.89 | $142.13 |
| Deferred revenue | $1427.71 | $1343.64 | $1152.87 | $777.89 |
| Short long term debt | ||||
| Total current liabilities | $2066.61 | $1925.89 | $1924.07 | $1325.6 |
| Long term debt | $96.97 | $100.33 | $102.66 | $64.44 |
| Total noncurrent liabilities | $386.78 | $420.7 | $395.32 | $270.22 |
| Total debt | $96.97 | $100.33 | $102.66 | $64.44 |
| Total liabilities | $2453.39 | $2346.59 | $2319.4 | $1595.82 |
| Shareholders' equity | ||||
| Retained earnings | $2447.17 | $2566.69 | $2619.37 | $2215.8 |
| Other shareholder equity | $3630.49 | $3601.36 | $4.33 | $43.5 |
| Total shareholder equity | $3630.49 | $3601.36 | $3622.71 | $3233.86 |
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $977.87 | $1028.49 | $956.73 | |
| Cost of revenue | ||||
| Gross Profit | $681.77 | $722.63 | $669.52 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $519.41 | $544.45 | $484.66 | |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $49.97 | $47.3 | $48.87 | |
| Interest expense | $4 | $3.3 | $4.98 | |
| Net income | ||||
| Net income | $115.96 | $96.56 | $124.01 | |
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3862.26 | $3734.64 | $2471.94 | |
| Cost of revenue | $1100.86 | $708.71 | ||
| Gross Profit | $2706.86 | $2633.78 | $1763.23 | |
| Operating activities | ||||
| Research & development | $305.26 | $175.31 | ||
| Selling, general & administrative | $1674.47 | $1200.76 | ||
| Total operating expenses | $2050.21 | $1991.18 | $1376.06 | |
| Operating income | $642.6 | $387.17 | ||
| Income from continuing operations | ||||
| EBIT | $599.06 | $378.95 | ||
| Income tax expense | $196.15 | $237.48 | -$1396.94 | |
| Interest expense | $17.26 | |||
| Net income | ||||
| Net income | $445.05 | $361.57 | $1775.89 | |
| Income (for common shares) | $361.57 | $1775.89 | ||
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $96.56 | $105.03 | $124.01 | |
| Operating activities | ||||
| Depreciation | $45.59 | $42.56 | $42.8 | |
| Business acquisitions & disposals | -$77.08 | |||
| Stock-based compensation | $47.03 | $38.79 | $38.83 | |
| Total cash flows from operations | $159.83 | $28.66 | $46.9 | |
| Investing activities | ||||
| Capital expenditures | -$53.45 | -$9.37 | -$33.41 | |
| Investments | -$59.18 | $6.87 | $19.94 | |
| Total cash flows from investing | -$201 | -$112.49 | -$79.58 | -$13.32 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$150.01 | $14.34 | -$310 | |
| Net borrowings | ||||
| Total cash flows from financing | -$152.7 | -$151.56 | -$11.72 | -$350.28 |
| Effect of exchange rate | $6.01 | -$0.19 | -$9 | $15.88 |
| Change in cash and equivalents | $104.46 | -$104.42 | -$71.64 | -$300.83 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $445.05 | $361.57 | $772.02 | $1775.89 |
| Operating activities | ||||
| Depreciation | $175.51 | $156.31 | $135.54 | $116 |
| Business acquisitions & disposals | -$12.3 | -$8 | -$420.79 | |
| Stock-based compensation | $154.03 | $133.37 | $114.34 | $98.43 |
| Total cash flows from operations | $785.78 | $568.73 | $1172.54 | $662.17 |
| Investing activities | ||||
| Capital expenditures | -$177.72 | -$291.9 | -$401.1 | -$154.92 |
| Investments | -$18.5 | $93.1 | -$192.72 | $343.04 |
| Total cash flows from investing | -$195.94 | -$213.32 | -$563.43 | -$231.51 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$575.76 | -$448.89 | -$349.42 | $20.31 |
| Net borrowings | ||||
| Total cash flows from financing | -$598.34 | -$501.69 | -$458.33 | -$30.81 |
| Effect of exchange rate | $4.67 | -$11.51 | -$12.12 | $10.48 |
| Change in cash and equivalents | -$3.84 | -$157.78 | $138.66 | $410.34 |
News
Fundamentals
| Market cap | $16.37B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 74.70M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | 1.84% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.68 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.26 |
| Quick ratio | 1.14 |